基本資料
種類: ETF
費用比率%: --
資產淨值: 24.69
成立日期: 16/09/2026
 
分析
市值分佈:
79.56%
大市值
15.76%
中市值
2.86%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 88  
0%
 
100%
     10大 (28.31%)
代號 名稱 佔比% ▼ 持有日期
TNGXTango Therapeutics1.5831/10/2026
ARWRArrowhead Pharmaceuticals1.5531/10/2026
RLAYRelay Therapeutics1.5131/10/2026
MDGLMadrigal Pharmaceuticals1.4431/10/2026
ERASErasca1.4331/10/2026
TVTXTravere Therapeutics1.3831/10/2026
TWSTTwist Bioscience Corp1.3731/10/2026
IRONDisc Medicine1.3631/10/2026
ALNYAlnylam Pharmaceuticals1.3331/10/2026
DYNDyne Therapeutics1.2931/10/2026
VRDNViridian Therapeutics1.2131/10/2026
BEAMBeam Therapeutics1.1931/10/2026
GRALGRAIL Inc.1.1931/10/2026
BIIBBiogen1.1731/10/2026
NRIXNurix Therapeutics1.1531/10/2026
KRYSKrystal Biotech1.0631/10/2026
CLDXCelldex Therapeutics1.0431/10/2026
DNLIDenali Therapeutics1.0331/10/2026
HALOHalozyme Therapeutics1.0131/10/2026
AMGNAmgen1.0031/10/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.